Prognostic modeling of individual patient risk and mortality impact of ischemic and hemorrhagic complications: assessment from the Acute Catheterization and Urgent Intervention Triage Strategy trial.
Pocock, Stuart J
Prognostic modeling of individual patient risk and mortality impact of ischemic and hemorrhagic complications: assessment from the Acute Catheterization and Urgent Intervention Triage Strategy trial. [electronic resource] - Circulation Jan 2010 - 43-51 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1524-4539
10.1161/CIRCULATIONAHA.109.878017 doi
Acute Coronary Syndrome--drug therapy
Aged
Aged, 80 and over
Female
Fibrinolytic Agents--adverse effects
Hemorrhage--chemically induced
Heparin--adverse effects
Hirudins--adverse effects
Humans
Logistic Models
Male
Middle Aged
Multivariate Analysis
Myocardial Infarction--mortality
Myocardial Ischemia--drug therapy
Peptide Fragments--adverse effects
Platelet Glycoprotein GPIIb-IIIa Complex--antagonists & inhibitors
Predictive Value of Tests
Prognosis
Randomized Controlled Trials as Topic--statistics & numerical data
Recombinant Proteins--adverse effects
Retrospective Studies
Risk Factors
Prognostic modeling of individual patient risk and mortality impact of ischemic and hemorrhagic complications: assessment from the Acute Catheterization and Urgent Intervention Triage Strategy trial. [electronic resource] - Circulation Jan 2010 - 43-51 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1524-4539
10.1161/CIRCULATIONAHA.109.878017 doi
Acute Coronary Syndrome--drug therapy
Aged
Aged, 80 and over
Female
Fibrinolytic Agents--adverse effects
Hemorrhage--chemically induced
Heparin--adverse effects
Hirudins--adverse effects
Humans
Logistic Models
Male
Middle Aged
Multivariate Analysis
Myocardial Infarction--mortality
Myocardial Ischemia--drug therapy
Peptide Fragments--adverse effects
Platelet Glycoprotein GPIIb-IIIa Complex--antagonists & inhibitors
Predictive Value of Tests
Prognosis
Randomized Controlled Trials as Topic--statistics & numerical data
Recombinant Proteins--adverse effects
Retrospective Studies
Risk Factors